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Introduction 44 Quality control of cells is crucial for biopharmaceutical manufacturing as well as 45 research. In research, many cell lines have been misidentified (http://iclac.org/wp- medicines that are currently marketed, although anti-HCV vaccines have not been 90 developed. 91 We determined the whole-genome sequences of Huh7 and Huh7.5.1-8 cell lines and 92 found characteristic genomic deletions in Huh7 and Huh7.5.1-8, some of which are 93 applicable to an in-house test for cell authentication. In addition, among the genes related 94 to HCV infection and replication, 53 genes were found to carry missense or loss-of-95 function (LoF) mutations that were not registered in the public germline mutation 96 databases, but were found in the Huh7 and/or Huh7.5.1-8. Among them, 8 genes, 97 including DDX58 (RIG-I), BAX, EP300, and SPP1 (osteopontin), contained mutations 98 observed only in Huh7.5.1-8 or mutations with higher frequency in Huh7.5.1-8. were obtained from the Japanese Collection of Research Bioresources (JCRB) Cell Bank. 104 We confirmed that the HCV replication is slower in JCRB0403 than Huh7.5.1-8 (data not The sites with read depths of ≥14 and ≤100 were used for the following variant calling. 129 The number of sites with ≥14 read depth covered >95% of the reference human genome variants were kept for further analyses as a novel variant. 137 We defined three categories of newly identified SNVs according to their frequency in 138 Huh7 and Huh7.5.1-8. We tested whether the SNV frequency is higher in Huh7 or As with the SNV calling, we only considered the sites with read depths of ≥14 and ≤100.
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The estimated structural variant frequency in Manta was difficult when we did not obtain 154 9 a sufficient number of reads spanning breakpoints. Therefore, we classified the structural PrimeSTAR GXL DNA Polymerase (Takara Bio, Otsu, Japan) was used for amplification. 186 The reaction mixture, containing 60 ng genome DNA, was denatured at 98°C for 1 min 187 and then subjected to 40 cycles, consisting of 98°C for 10 s, 61°C for 15 s, and 68°C, for Supplementary Table 1 . 269 We successfully amplified six regions by genomic PCR and confirmed that they all were also classified as LoF mutations. 280 Among these mutations, we selected genes that have missense and/or LoF mutations. 281 We confirmed that missense mutations are present in the RNA-seq read data, which means 282 that mutated alleles are actually expressed in the cells. In total, 255 and 431 genes were 283 found to have missense and LoF mutations, respectively. The complete list of genes is 284 shown in Supplementary Data 1. 285 We narrowed down the gene list and chose several genes that might be relevant to the 286 HCV replication process. We reviewed previous research and selected keywords that are , CLDN1, EGFR, EPHA2, LDLR, OCLN, PPIA, and SCARB1) . 292 We identified 53 candidate genes, including 12 autophagy-related genes, 22 apoptosis-293 related genes, 3 antiviral defense genes, 14 HCV-related genes, 8 innate immune-related 294 genes, 4 serine proteases, and 4 genes involved in the HCV core-gene network. Eleven 295 genes were categorized into two different classes. The list of genes and mutations is 296 summarized in Table 2 . Two HLA genes, HLA-DRB1 and HLA-DRB5, related to an 297 acquired immune system, contained several LoF mutations shared between Huh7 and 298 Huh7.5.1-8, albeit those genes were not included in the 53 genes in Table 2 since cultured   299 cells lack the acquired immune system. Interestingly, among the 53 candidate genes, 8 300 genes contained Huh7.5.8-1+ mutations, but none carried Huh7-predominant mutations. 301 Among the 8 genes, 4 genes (BAX, COL6A3, DEFB104B, and SIRPB1) had LoF 302 mutations, whereas the other 4 genes (DDX58, EP300, SPP1, and ZNF654) had missense 303 mutations ( Table 2) . Future studies will be required to elucidate whether these mutations 304 are relevant to the phenotypes of the Huh7 cell lineage. 305 One of the genes, DDX58, which is also known as RIG-I, encodes an RNA helicase 306 and has an important function for innate antiviral response (Yoneyama et al., 2004) . The 307 mutation is, therefore, a strong candidate for the high permissiveness of HCV in the 308 Huh7.5 lineage. It is noteworthy that our whole-genome sequence approach also 309 identified this gene. However, we found a difference in the mutation frequency between 310 the results of this and previous studies. This incongruence is discussed in the next Missense mutation in RIG-I (T55I) was heterologous in the Huh7.5.1-8 genome 346 As described in the above subsection, we found a T55I mutation in RIG-I that could 347 contribute to the high permissiveness to HCV in Huh7.5.1-8. However, both genome 348 sequencing and RNA-seq data showed the mutation is heterologous in Huh7.5.1-8, 349 contradicting previous findings that the mutation is homozygous in Huh7.5 (Sumpter et   350 
